Literature DB >> 2073135

DNA damage induced by doxorubicin, 4'-epidoxorubicin and their copper(II) complexes.

D Cova, M Sassano, E Monti, F Piccinini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2073135     DOI: 10.1007/BF01971842

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


× No keyword cloud information.
  9 in total

1.  Nonenzymatic oxygen activation and stimulation of lipid peroxidation by doxorubicin-copper.

Authors:  K B Wallace
Journal:  Toxicol Appl Pharmacol       Date:  1986-10       Impact factor: 4.219

2.  Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents.

Authors:  J W Lown; S K Sim; K C Majumdar; R Y Chang
Journal:  Biochem Biophys Res Commun       Date:  1977-06-06       Impact factor: 3.575

3.  Oxygen enhancement of free radical damage to DNA. A comparison of radiation-induced degradation with copper-catalyzed degradation by H2O2.

Authors:  W A Prütz
Journal:  Free Radic Res Commun       Date:  1989

4.  Unusual copper-induced sensitization of the biological damage due to superoxide radicals.

Authors:  A Samuni; M Chevion; G Czapski
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

5.  Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex.

Authors:  C E Myers; L Gianni; C B Simone; R Klecker; R Greene
Journal:  Biochemistry       Date:  1982-04-13       Impact factor: 3.162

6.  Transfer of ferritin-bound iron to adriamycin.

Authors:  E J Demant
Journal:  FEBS Lett       Date:  1984-10-15       Impact factor: 4.124

7.  The adriamycin-iron(III) complex is a potent inhibitor of protein kinase C.

Authors:  Y A Hannun; R J Foglesong; R M Bell
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

8.  Oxidative destruction of DNA by the adriamycin-iron complex.

Authors:  H Eliot; L Gianni; C Myers
Journal:  Biochemistry       Date:  1984-02-28       Impact factor: 3.162

9.  Hydroxyl radical production and DNA damage induced by anthracycline-iron complex.

Authors:  J R Muindi; B K Sinha; L Gianni; C E Myers
Journal:  FEBS Lett       Date:  1984-07-09       Impact factor: 4.124

  9 in total
  1 in total

Review 1.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.